Immunogenicity and safety of a novel recombinant protective antigen anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled phase II clinical study
- Chang Kyung Kang
- , Nak Hyun Kim
- , Chung Jong Kim
- , Gi eun Rhie
- , Su Kyoung Jo
- , Misun Ahn
- , Jieun Kang
- , Pyoeng Gyun Choe
- , Wan Beom Park
- , Nam Joong Kim
- , Myoung don Oh
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations